PHIO Earnings Date: Nov 12, 2026 (Estimated) — Phio Pharmaceuticals Corp.
NASDAQ · Healthcare · Biotechnology
Updated
When is PHIO's next earnings date?
Phio Pharmaceuticals Corp. (PHIO) is expected to report Q3 2026 earnings on Thursday, November 12, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.36.
How did PHIO do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Phio Pharmaceuticals Corp. posted EPS of -$0.36 versus the -$0.36 estimate, an in-line result. Revenue was $0. The stock's 1-day post-earnings move was -1.9%.
How much does PHIO stock move after earnings?
PHIO beat EPS estimates in 4 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 3.3% (up or down) in the day after earnings.
About Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene expression in both T cells and tumor cells in preclinical studies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was founded in 2003 and is based in King Of Prussia, Pennsylvania.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | -0.36 | -0.36 | +0.00% | $0 | ➖ Inline | -1.89% | +2.83% | +1.89% |
| 2026-05-07 | Q1 2026 | -0.23 | -0.34 | -47.83% | $0 | ❌ Miss | -6.14% | -1.75% | -4.39% |
| 2026-03-05 | Q4 2025 | -0.42 | -0.15 | +64.29% | $0 | ✅ Beat | -0.85% | +6.84% | +7.69% |
| 2025-11-13 | Q3 2025 | -0.44 | -0.44 | +0.00% | $0 | ➖ Inline | -9.09% | -16.78% | -23.78% |
| 2025-03-31 | Q4 2024 | -3.60 | -0.85 | +76.39% | $0 | ✅ Beat | -5.38% | -20.77% | +47.69% |
| 2024-11-14 | Q3 2024 | -4.14 | -1.54 | +62.80% | $0 | ✅ Beat | -0.90% | +13.45% | +27.35% |
| 2024-08-14 | Q2 2024 | -0.51 | -3.62 | -609.80% | $0 | ❌ Miss | -1.53% | +17.56% | +25.57% |
| 2024-04-02 | Q4 2023 | -11.70 | -1.53 | +86.92% | $0 | ✅ Beat | +0.60% | +3.62% | +4.35% |
Showing last 8 quarters.